首页> 美国卫生研究院文献>Frontiers in Aging Neuroscience >The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis
【2h】

The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis

机译:相对丘脑萎缩(yrRTA)的年率:一种简单的2D / 3D方法估计多发性硬化症中深层灰质萎缩

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite a strong correlation to outcome, the measurement of gray matter (GM) atrophy is not being used in daily clinical practice as a prognostic factor and monitor the effect of treatments in Multiple Sclerosis (MS). This is mainly because the volumetric methods available to date are sophisticated and difficult to implement for routine use in most hospitals. In addition, the meanings of raw results from volumetric studies on regions of interest are not always easy to understand. Thus, there is a huge need of a methodology suitable to be applied in daily clinical practice in order to estimate GM atrophy in a convenient and comprehensive way. Given the thalamus is the brain structure found to be more consistently implied in MS both in terms of extent of atrophy and in terms of prognostic value, we propose a solution based in this structure. In particular, we propose to compare the extent of thalamus atrophy with the extent of unspecific, global brain atrophy, represented by ventricular enlargement. We name this ratio the “yearly rate of Relative Thalamic Atrophy” (yrRTA). In this report we aim to describe the concept of yrRTA and the guidelines for computing it under 2D and 3D approaches and explain the rationale behind this method. We have also conducted a very short crossectional retrospective study to proof the concept of yrRTA. However, we do not seek to describe here the validity of this parameter since these researches are being conducted currently and results will be addressed in future publications.
机译:尽管与结局密切相关,但日常临床实践并未将灰质(GM)萎缩的测量作为预后因素,并监测多发性硬化症(MS)的治疗效果。这主要是因为迄今为止可用的体积方法复杂且难以在大多数医院中常规使用。此外,对感兴趣区域进行体积研究得出的原始结果的含义并不总是易于理解。因此,迫切需要适合于在日常临床实践中应用的方法,以便以方便且全面的方式估计GM萎缩。鉴于丘脑是在萎缩程度和预后价值方面均更一致地隐含于MS中的大脑结构,我们提出了基于这种结构的解决方案。特别是,我们建议比较丘脑萎缩程度与以脑室扩大为代表的非特异性全脑萎缩程度。我们将此比率称为“每年相对丘脑萎缩率”(yrRTA)。在本报告中,我们旨在描述yrRTA的概念以及在2D和3D方法下计算yrRTA的指南,并解释该方法背后的原理。我们还进行了非常短的阴囊回顾性研究,以证明yrRTA的概念。但是,由于这些研究目前正在进行中,并且我们的结果将在以后的出版物中讨论,因此我们在此不寻求描述此参数的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号